Our research demonstrated for the first time that exosomes derived from colon cancer cells carry ENTPD2, which promotes ATP–adenosine metabolism and induces the formation of an immunosuppressive microenvironment. The gene discussed is ENTPD2; the disease is malignant colon neoplasm.